Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
SANTA CLARA, Calif., March 02, 2021 Highlights: Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Furthers Agilent’s participation in fast-growing NGS technologies for precision... Read more